The Recall Desk
ModerateFDA (Drugs)·D-1094-2014·Announced 2014-03-12

Teva Recalls Dextroamphetamine Tablets Due to CGMP Deviations

Teva Pharmaceuticals is recalling specific lots of Dextroamphetamine tablets because they were manufactured using unapproved material and not properly quarantined.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which is a moderate risk. The source text does not report any illnesses, injuries, or deaths, and the hazard is related to manufacturing deviations (unapproved material/quarantine) rather than a confirmed high-risk pathogen or structural defect.

Plain-English summary

Teva Pharmaceuticals USA is recalling Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10 mg. The affected product is a prescription-only medication (CII) distributed nationwide in 100-count bottles. The specific lot number is 34017575A with an expiration date of 10/16.

The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The finished product was manufactured using unapproved material and was not properly quarantined as rejected due to inadequate cleaning of equipment. The total quantity involved in the recall is 9,796 tablets.

Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product matches the recalled lot, it should be returned to the pharmacy or point of purchase for a refund or replacement. Patients should consult their healthcare provider for alternative treatment options if necessary.

The recalled product

Product
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE)
Brand
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
Manufacturer
Teva Pharmaceuticals USA
Category
Drug — Prescription Stimulant
Hazard
Affected units
9,796

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 34017575A
  • Exp. 10/16.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 4 recalled by Teva Pharmaceuticals USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →

Related recalls

Same brand · DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Same manufacturer · Teva Pharmaceuticals USA

See all →

Same hazard · cgmp deviation

See all →